Idebenone and Idebenone for Mitochondrial disease (specific)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Idebenone
A synthetic CoQ10 relative with niche evidence in specific mitochondrial diseases, not general use.
Grade C1 graded outcomerevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Idebenone for Mitochondrial disease (specific)
Evidence grade C — Niche, medical
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Idebenone | Idebenone for Mitochondrial disease (specific) |
|---|---|---|
| Mitochondrial disease (specific) | Evidence grade CModerate effectmixedNiche, medical | Evidence grade CModerate effectmixedNiche, medical |
Graded only in Idebenone
None — every outcome it grades is graded in both.
Graded only in Idebenone for Mitochondrial disease (specific)
None — every outcome it grades is graded in both.
What each entry says about the other
- Idebenone for Mitochondrial disease (specific)’s entry · Goes with: Read the full Idebenone monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.